Multistate Model Tracks Recurrence and Survival After Colorectal Liver Metastasis Resection

The article summarizes a four-state illness–death model developed from an international, multi-institutional cohort of 3,002 patients who underwent curative-intent resection of colorectal liver metastases. The modeled states were alive without recurrence, alive after recurrence, colorectal cancer-related death, and death from other causes. The approach was intended to represent recurrence as an event that changes subsequent prognosis, rather than relying on a single disease-free or overall survival endpoint.

Recurrence occurred in more than half of patients, and fewer than one in four remained alive and recurrence free at five years. Estimated five-year recurrence risk declined from 23.9% among patients recurrence free at six months to 4.3% among those recurrence free at four years. The probability of colorectal cancer-related death by five years was 65.6% among patients who had recurred by six months, compared with 37.2% among those recurrence free at that point. Tumor burden score was associated with recurrence (HR 1.06 per unit), while adjuvant chemotherapy was associated with lower risks of recurrence (HR 0.76) and colorectal cancer-related death from the recurrence-free state (HR 0.39).

The authors suggest that conditional risk estimates may eventually inform surveillance and counseling. They note that external and prospective validation is needed before dynamic prediction tools enter routine care; the model also does not account for several factors, including molecular markers and multiple recurrences.